BASELINE CHARACTERISTICS FROM AN OBSERVATIONAL STUDY (DRAKO) INVESTIGATING OUTCOMES OF INTRAVITREAL AFLIBERCEPT INJECTIONS FOR TREATMENT OF DIABETIC MACULAR OEDEMA (DMO) IN THE UK

被引:0
|
作者
Kotagiri, A. [1 ]
Sivaprasad, S. [2 ]
Kelly, S. [3 ]
Ghanchi, F. [4 ]
Talks, J. [5 ]
Scanlon, P. H. [6 ]
Saddiq, M. [7 ]
Niton, J. [8 ]
机构
[1] City Hosp Sunderland NHS Fdn Trust, Sunderland, Tyne & Wear, England
[2] Moorfields Biomed Res Ctr, Natl Inst Hlth Res, London, England
[3] Bolton Hosp NHS Fdn Trust, Bolton, England
[4] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England
[5] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[6] Gloucestershire Hosp NHS Fdn Trust, Cheltenham, Glos, England
[7] O4 Res Ltd, Belfast, Antrim, North Ireland
[8] Bayer PLC, Reading, Berks, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:NP27 / NP27
页数:1
相关论文
共 50 条
  • [1] Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P. P.
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    McGoey, Hellen
    Nolan, Andrew
    Saddiq, Moneeb
    Napier, Jackie
    Morgan-Warren, Peter
    [J]. EYE, 2023, 37 (12) : 2527 - 2534
  • [2] Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes
    Sobha Sivaprasad
    Faruque Ghanchi
    Simon P. Kelly
    Ajay Kotagiri
    James Talks
    Peter Scanlon
    Hellen McGoey
    Andrew Nolan
    Moneeb Saddiq
    Jackie Napier
    Peter Morgan-Warren
    [J]. Eye, 2023, 37 : 2527 - 2534
  • [3] Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes
    Sobha Sivaprasad
    Faruque Ghanchi
    Simon P. Kelly
    Ajay Kotagiri
    James Talks
    Peter Scanlon
    Hellen McGoey
    Andrew Nolan
    Moneeb Saddiq
    Jackie Napier
    [J]. Eye, 2023, 37 : 2753 - 2760
  • [4] Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    McGoey, Hellen
    Nolan, Andrew
    Saddiq, Moneeb
    Napier, Jackie
    [J]. EYE, 2023, 37 (13) : 2753 - 2760
  • [5] Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James
    Scanlon, Peter
    McGoey, Hellen
    Nolan, Andrew
    Saddiq, Moneeb
    Napier, Jackie
    [J]. EYE, 2022, 36 (01) : 64 - 71
  • [6] Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes
    Sobha Sivaprasad
    Faruque Ghanchi
    Simon P. Kelly
    Ajay Kotagiri
    James Talks
    Peter Scanlon
    Hellen McGoey
    Andrew Nolan
    Moneeb Saddiq
    Jackie Napier
    [J]. Eye, 2022, 36 : 64 - 71
  • [7] How effective is intravitreal aflibercept in routine clinical practice among treatment-naive patients with diabetic macular oedema? Year 1 results from DRAKO, a prospective, observational study conducted in the UK
    Talks, J.
    [J]. DIABETIC MEDICINE, 2022, 39
  • [8] Real-life study assessing the effectiveness of intravitreal aflibercept injection (IAI) treatment of diabetic macular edema (DME) in UK routine clinical practice (DRAKO): Baseline Characteristics
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon
    Kotagiri, Ajay
    Talks, James S.
    Scanlon, Peter
    Saddiq, Moneeb
    Jain, Nitin
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [9] Intravitreal (IVT) ranibizumab injections for diabetic macular oedema (DMO): real world results
    Mourtzoukos, Spyridon
    [J]. EYE, 2017, 31 : S13 - S13
  • [10] Evaluation of Intravitreal Aflibercept Treatment Effectiveness in UK Routine Clinical Practice for Patients with Diabetic Macular Edema: 24-month Outcomes of the DRAKO Study
    Talks, J.
    Sivaprasad, S.
    Kelly, S. P.
    Ghanchi, F.
    Kotagiri, A.
    Saddiq, M.
    Scanlon, P.
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (1_SUPPL) : 7 - 8